Asia-Pacific Biochips Market – Size, Trends and Forecast (2024 – 2032)

Biochips are small laboratories which perform hundreds and thousands of biochemical reactions and decoding the genes in less time. Biochips are mostly used in the study of molecular biology. Biochips also known as biological microarray chips have transformed the healthcare industry to an extraordinary level and its applications have solved various health issues.

Asia Pacific Biochips Market Segments Size & Growth:

Asia Pacific BiochipMarket is accounted for $ 2 billion in 2017 and expected to grow at a CAGR of 25.2% to reach $7.9 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by rising in the usage of personalised medicine, rapid diagnosis, and investments from the government. However, high cost and lack of awareness related to biological microarray hinder the growth of the Asia Pacific Biochipmarket.

Asia Pacific Biochips Market Segments Share:

Asia Pacific Biochip Market is categorised into by product type which consists of tissues biochip, protein microarrays, DNA microarrays, carbohydrate biochips, and lab-on-chip. DNA microarrays have the most significant share because of increase in demand in the fields of proteomics and genomics. By application, Asia Pacific Biochip market is segmented as drug discovery, proteomics, cancer research, gene sequencing, and gene expression.  Among all drug discovery and gene expression are expected to have high growth rate during the forecast period 2018-2024, due to increase in demand for personalised medicine and genetic disorders.

By Geography, China is dominating the Asia Pacific biochip market, and the growth in the Asia Pacific is mainly attributed because of the increasing adoption of precision medicine and demand for rapid diagnostics.Furthermore, India is witnessing the fastest growth during the forecast period, due to rising patients, healthcare awareness and government funding.

Asia Pacific Biochip Market Segments Trends:

• In recent research done at IIT Hyderabad has developed a new device that can detect infectious malaria diseases at a little cost and accuracy in November 2017.
• In January 2017, Abbott Laboratories acquired St.Jude Medical Inc. to expand opportunities for diagnostics and pharmaceuticals.

Asia Pacific Biochip Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Cepheid Inc.
• Cellix
• Biomerieux SA
• Beckman Coulter Inc.
• FLUIDIGM CORPORATION